CannaWize combines public-record reporting, research interpretation, patient-access education, local knowledge, and firsthand hemp-retail perspective. We build projects that remain useful after a campaign ends.
Content licensing
Syndicated explainers, white-label education, local guides, newsletters, and custom editorial packages with agreed attribution and update terms.
Regulatory intelligence
Source monitoring, licensing calendars, policy briefs, jurisdiction summaries, and structured records with dates and primary-source links.
Medical and research collaboration
Credentialed review, evidence translation, expert interviews, patient education, research recruitment visibility, and transparent advisory participation.
Reports and events
Sponsored research with methodological independence, conference moderation, webinars, executive briefings, and educational series.
Who we want to hear from
Universities, clinicians, pharmacists, patient groups, laboratories, state and national associations, law and compliance firms, public-health organizations, publishers, event organizers, cannabis technology companies, and licensed operators with verifiable standards.
Non-negotiable safeguards
- No payment for favorable news or research conclusions.
- No unsubstantiated treatment, safety, or regulatory claims.
- No undisclosed sponsorship, affiliate relationship, or material conflict.
- No youth-oriented cannabis promotion.
- No fabricated audience, reviewer, testing, or performance claims.
- CannaWize retains correction rights and labels commercial work clearly.